Update on a real-world study evaluating overall survival and treatment duration in Swedish patients with metastatic castration-resistant prostate cancer treated with enzalutamide
DOI:
https://doi.org/10.1080/21681805.2020.1750476Abstract
No abstract availableDownloads
Download data is not yet available.
Downloads
Published
2020-03-05
How to Cite
Alghazali, M., Löfgren, A., Cheng, N., Fagerlund, K., & Bjartell, A. (2020). Update on a real-world study evaluating overall survival and treatment duration in Swedish patients with metastatic castration-resistant prostate cancer treated with enzalutamide. Scandinavian Journal of Urology, 54(3), 263–264. https://doi.org/10.1080/21681805.2020.1750476
Issue
Section
Articles
License
Acta Chirurgica Scandinavica Society owns the copyright for all material published until Volume 57 (2023) unless otherwise specified. As from Volume 59 (2024) all published articles, unless otherwise specified, are published under CC-BY licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, with the condition of proper attribution to the original work.
